Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

Today, 7:45 PM

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering rate hike fears.

ABBV

5 minute read

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates

By Shanthi Rexaline

Today, 7:45 PM

Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with it.

ABBV

4 minute read

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

By Shanthi Rexaline

Today, 7:45 PM

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.

ACIU

2 minute read

What’s Going On With Zai Lab, Hutchmed, BeiGene Shares Today

By Vandana Singh

Today, 7:45 PM

Three of the most major drugmakers with roots in China, Zai Lab Ltd (NASDAQ: ZLAB), BeiGene Ltd (NASDAQ: BGNE), and Hutchmed China Ltd (NASDAQ:

BGNE

1 minute read

Chinese Stocks Are Falling: What’s Going On?

By Adam Eckert

Today, 7:45 PM

Shares of multiple Chinese companies are trading lower Thursday following reports the U.S. Securities and Exchange Commision has identified multiple US-listed ADRs as having not adhered to the Holding Foreign Companies Accountable act (HFCAA).

ACMR